Antitumor Activity of VB-111, a Novel Antiangiogenic Virotherapeutic, in Thyroid Cancer Xenograft Mouse Models

VB-111 is an engineered antiangiogenic adenovirus that expresses Fas-c in angiogenic blood vessels and has previously been shown to have significant antitumor activity in vitro and in vivo in Lewis lung carcinoma, melanoma, and glioblastoma models. To evaluate the efficacy of VB-111 in thyroid cance...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Reddi, H. V., Madde, P., Cohen, Y. C., Bangio, L., Breitbart, E., Harats, D., Bible, K. C., Eberhardt, N. L.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: SAGE Publications 2011
Gaiak:
Short Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3374632/
https://ncbi.nlm.nih.gov/pubmed/22701765
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1947601912437933
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak